Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆

Filippo Montemurro

Roche (Switzerland)

Suzette Delaloge

Institut Gustave Roussy

Carlos H. Barrios

Centro Brasileiro de Estudos em Dermatologia

Annals of Oncology

Ludwig-Maximilians-Universität München

Istituti di Ricovero e Cura a Carattere Scientifico

Institut Gustave Roussy